
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12160287
[patent_doc_number] => 20180031553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'SYSTEMS, METHODS, AND WORKFLOWS FOR OPTOGENETICS ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 15/645426
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27515
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645426 | Systems, methods, and workflows for optogenetics analysis | Jul 9, 2017 | Issued |
Array
(
[id] => 14468445
[patent_doc_number] => 20190185865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => USE OF PROKARYOTIC TRANSCRIPTIONAL ACTIVATORS AS METABOLITE BIOSENSORS IN EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/311506
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311506 | USE OF PROKARYOTIC TRANSCRIPTIONAL ACTIVATORS AS METABOLITE BIOSENSORS IN EUKARYOTIC CELLS | Jul 5, 2017 | Abandoned |
Array
(
[id] => 17434775
[patent_doc_number] => 11260081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Engineered parasites for delivering protein to the central nervous system (CNS)
[patent_app_type] => utility
[patent_app_number] => 16/313060
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 63
[patent_no_of_words] => 67848
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313060 | Engineered parasites for delivering protein to the central nervous system (CNS) | Jun 28, 2017 | Issued |
Array
(
[id] => 12119164
[patent_doc_number] => 20180002750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'LONG LIFETIME ALPHA-HEMOLYSIN NANOPORES'
[patent_app_type] => utility
[patent_app_number] => 15/638273
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16624
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638273 | LONG LIFETIME ALPHA-HEMOLYSIN NANOPORES | Jun 28, 2017 | Abandoned |
Array
(
[id] => 13137429
[patent_doc_number] => 10086025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Method of identifying a biologically-active composition from a biofilm
[patent_app_type] => utility
[patent_app_number] => 15/626971
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14710
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626971 | Method of identifying a biologically-active composition from a biofilm | Jun 18, 2017 | Issued |
Array
(
[id] => 17060121
[patent_doc_number] => 11104708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Articles comprising a silk polypeptide for antigen delivery
[patent_app_type] => utility
[patent_app_number] => 16/307622
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 22566
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307622
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307622 | Articles comprising a silk polypeptide for antigen delivery | Jun 12, 2017 | Issued |
Array
(
[id] => 13714409
[patent_doc_number] => 20170368159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 15/619075
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619075 | Lipidated | Jun 8, 2017 | Issued |
Array
(
[id] => 13746711
[patent_doc_number] => 10166280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => Polypeptides and immunizing compositions containing
[patent_app_type] => utility
[patent_app_number] => 15/617541
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27645
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617541 | Polypeptides and immunizing compositions containing | Jun 7, 2017 | Issued |
Array
(
[id] => 11962269
[patent_doc_number] => 20170266422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHODS AND SYSTEMS FOR TOXIN DELIVERY TO THE NASAL CAVITY'
[patent_app_type] => utility
[patent_app_number] => 15/615344
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 12464
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615344 | Methods and systems for toxin delivery to the nasal cavity | Jun 5, 2017 | Issued |
Array
(
[id] => 12090570
[patent_doc_number] => 20170347663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'NON-AQUEOUS, NON-OIL BACILLUS AMYLOLIQUEFACIENS COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/612369
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2907
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612369 | Non-aqueous, non-oil | Jun 1, 2017 | Issued |
Array
(
[id] => 12090571
[patent_doc_number] => 20170347665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'NON-AQUEOUS, NON-OIL LIVE MICROBIAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/612391
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3209
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612391 | Non-aqueous, non-oil live microbial compositions | Jun 1, 2017 | Issued |
Array
(
[id] => 12975907
[patent_doc_number] => 20170340719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => IMMUNOGENIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/606439
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606439
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606439 | Immunogenic composition | May 25, 2017 | Issued |
Array
(
[id] => 11956072
[patent_doc_number] => 20170260224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'NANOPARTICLES, PROCESS FOR PREPARATION AND USE THEREOF AS CARRIER FOR AMPHIPATIC AND HYDROPHOBIC MOLECULES IN FIELDS OF MEDICINE INCLUDING CANCER TREATMENT AND FOOD RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/605595
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16546
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/605595 | Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds | May 24, 2017 | Issued |
Array
(
[id] => 13699921
[patent_doc_number] => 20170360915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/604054
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604054 | Adjuvanting meningococcal factor H binding protein | May 23, 2017 | Issued |
Array
(
[id] => 13854025
[patent_doc_number] => 10188719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Conjugation of
[patent_app_type] => utility
[patent_app_number] => 15/592339
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 14158
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/592339 | Conjugation of | May 10, 2017 | Issued |
Array
(
[id] => 14213867
[patent_doc_number] => 20190119318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Separation Matrix
[patent_app_type] => utility
[patent_app_number] => 16/096952
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096952 | Separation matrix | May 9, 2017 | Issued |
Array
(
[id] => 12029534
[patent_doc_number] => 20170319634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'COMPOSITIONS COMPRISING BACTERIAL STRAINS'
[patent_app_type] => utility
[patent_app_number] => 15/592178
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 23963
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592178
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/592178 | Compositions comprising bacterial strains | May 9, 2017 | Issued |
Array
(
[id] => 13812619
[patent_doc_number] => 10183067
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-01-22
[patent_title] => TAA/CD4OL composition/vaccine for malaria
[patent_app_type] => utility
[patent_app_number] => 15/587777
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8086
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587777 | TAA/CD4OL composition/vaccine for malaria | May 4, 2017 | Issued |
Array
(
[id] => 14213895
[patent_doc_number] => 20190119332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHODS TO PURIFY AVIDIN-LIKE PROTEINS AND FUSION PROTEINS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/098258
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098258 | METHODS TO PURIFY AVIDIN-LIKE PROTEINS AND FUSION PROTEINS THEREOF | May 3, 2017 | Abandoned |
Array
(
[id] => 14697699
[patent_doc_number] => 10376572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Immunogenic composition for preventing pneumococcal diseases and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 15/582400
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5741
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/582400 | Immunogenic composition for preventing pneumococcal diseases and preparation method thereof | Apr 27, 2017 | Issued |